Mr. Chair, I'd have to look at exactly what those other two committees do to give you a complete answer.
I would say that, when the Canadian vaccine task force got started, we were just swamped with the need to identify, as quickly as possible, those vaccine candidates that would yield the very best vaccines for Canadians. Indeed, here we are now, seven months later. I think all of us feel very proud of the fact that the six candidates we identified, the international ones, are exactly the six that everyone in the world now wants. We did our due diligence, I think, absolutely correctly. That was our number one priority.
I think the second priority was, as you said, transparency or making things more open. I certainly think there would be room for us to do that. Part of the issue, of course, was that we were providing advice to ministers, which, as you know, is confidential in the parliamentary system. Second, there are some industry issues. Every company that came in front of us, both Canadian and international, required that we all sign confidentiality agreements with them. Indeed, there were confidential issues from the companies' points of view that we could not release, so there are some issues.